Business
GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
COLORADO SPRINGS, Colo., April 24, 2025--GE HealthCare (Nasdaq: GEHC), a global leader in breast health technology, will feature its latest advancements in diagnostic accuracy and patient-centered breast care during the 2025 Society of Breast Imaging Symposium in Colorado Springs, Co., April 24-27, 2025. This year’s showcase will feature new innovations designed to improve breast cancer detection, streamline workflows, and enhance overall patient care.
About this update from Ge Healthcare Technologies Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":6570,"height":2242,"url":"https://media.zenfs.com/en/business-wire.com/336d11604766370ca0620dafd41efab1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kVac_ahRqdOrUkHJy78JHQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/336d11604766370ca0620dafd41efab1","width":960,"height":328},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/5gAMpl8JaVmip2hG55tDRA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/336d11604766370ca0620dafd41efab1","width":1200,"height":409}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Pristina Via™ mammography system is designed to enhance the mammography experience with advanced diagnostic tools and streamlined exam workflows","length":144,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"GE HealthCare will distribute DeepHealth’s SmartMammo™, now commercially available in the U.S., to harness the power of AI to streamline radiology workflows","length":156,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Invenia™ Automated Breast Ultrasound (ABUS) Premium is the first FDA-approved breast ultrasound supplemental screening technology specifically designed for detecting cancer in dense breasts","length":189,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"SenoBright™ HD and SerenaBright™ are the first FDA-cleared Contrast Enhanced Mammography (CEM) and CEM biopsy solutions designed to complement mammograms with functional insights","length":178,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":667,"olType":false},{"type":"text","content":"COLORADO SPRINGS, Colo., April 24, 2025--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a global leader in breast health technology, will feature its latest advancements in diagnostic accuracy and patient-centered breast care during the 2025 Society of Breast Imaging Symposium in Colorado Springs, Co., April 24-27, 2025. This year’s showcase will feature new innovations designed to improve breast cancer detection, streamline workflows, and enhance overall patient care.","length":473,"tagName":"p"},{"type":"text","content":"Mammography innovations ...